TY - JOUR T1 - Deep RNA Sequencing of Intensive Care Unit Patients with COVID-19 JF - medRxiv DO - 10.1101/2021.01.11.21249276 SP - 2021.01.11.21249276 AU - Sean F. Monaghan AU - Alger M. Fredericks AU - Maximilian S. Jentzsch AU - William G. Cioffi AU - Maya Cohen AU - William G. Fairbrother AU - Shivam J. Gandhi AU - Elizabeth O. Harrington AU - Gerard J. Nau AU - Jonathan S. Reichner AU - Corey E. Ventetuolo AU - Mitchell M. Levy AU - Alfred Ayala Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/13/2021.01.11.21249276.abstract N2 - Purpose COVID-19 has impacted millions of patients across the world. Molecular testing occurring now identifies the presence of the virus at the sampling site: nasopharynx, nares, or oral cavity. RNA sequencing has the potential to establish both the presence of the virus and define the host’s response in COVID-19.Methods Single center, prospective study of patients with COVID-19 admitted to the intensive care unit where deep RNA sequencing (>100 million reads) of peripheral blood with computational biology analysis was done. All patients had positive SARS-CoV-2 PCR. Clinical data was prospectively collected.Results We enrolled fifteen patients at a single hospital. Patients were critically ill with a mortality of 47% and 67% were on a ventilator. All the patients had the SARS-CoV-2 RNA identified in the blood in addition to RNA from other viruses, bacteria, and archaea. The expression of many immune modulating genes, including PD-L1 and PD-L2, were significantly different in patients who died from COVID-19. Some proteins were influenced by alternative transcription and splicing events, as seen in HLA-C, HLA-E, NRP1 and NRP2. Entropy calculated from alternative RNA splicing and transcription start/end predicted mortality in these patients.Conclusions Current upper respiratory tract testing for COVID-19 only determines if the virus is present. Deep RNA sequencing with appropriate computational biology may provide important prognostic information and point to therapeutic foci to be precisely targeted in future studies.Take Home Message Deep RNA sequencing provides a novel diagnostic tool for critically ill patients. Among ICU patients with COVID-19, RNA sequencings can identify gene expression, pathogens (including SARS-CoV-2), and can predict mortality.Tweet Deep RNA sequencing is a novel technology that can assist in the care of critically ill COVID-19 patients & can be applied to other diseaseCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by funding from the US National Institutes of Health: P20 GM103652 (SFM, WGF, EOH, AA), T32 HL134625 (AMF, EOH), R01 GM 127472 (WGF), P20 GM121344 (GJN), R01 HL147525 (JSR), R01 HL141268 (CEV), R35 GM118097 (AA).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Rhode Island Hospital Institutional Review Board approved this study (# 411616). Informed consent was given by all patients or surrogates.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMuch of the data is supplied in the supplemental materials. Specific patient level data is not included due to privacy. ER -